Home > Insider Trading > Juno Therapeutics Inc.

Juno Therapeutics Inc. (JUNO)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 16

Hedge Funds Abandoning Juno Therapeutics Inc (JUNO) In Droves

Hedge funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September.

Keep Reading →

November 20th, 2015 - Hedge Funds News

Juno Therapeutics Inc (JUNO) Shares Spike 27% In Morning Trading: Will Bearish Hedgies Change Their Minds?

Juno Therapeutics Inc (NASDAQ:JUNO) jumped to a $67.22 per share pre-market high today, or 45.18% from the stock’s closing price yesterday, as the company announced that it has agreed to a ten-year ...

Keep Reading →

June 30th, 2015 - Hedge Funds News

Steadymed Ltd (STDY), Achillion Pharmaceuticals, Inc. (ACHN), & Nevro Corp (NVRO): James Flynn's Latest Healthcare Picks

James E.

Keep Reading →

March 27th, 2015 - Hedge Funds News

JUNO Therapeutics Inc (JUNO); Coherus Biosciences Inc (CHRS), Stemline Therapeutics Inc (STML): VCHP's Bullish Sentiment Pays Off

Juno Therapeutics Inc (NASDAQ:JUNO) is up by 15% as of Thursday afternoon, following the release of its first-ever earnings report since its IPO.

Keep Reading →

March 19th, 2015 - Hedge Funds News

Regulus Therapeutics Inc (RGLS), Trevena Inc (TRVN), Juno Therapeutics Inc (JUNO): RA Capital's Top New Biotech Picks

Peter Kolchinsky’s RA Capital Management filed its latest 13F with the Securities and Exchange Commission in February, and we’ve gone through the data to highlight three of its top new picks in the...

Keep Reading →

March 4th, 2015 - Hedge Funds News

Juno Therapeutics Inc (JUNO), Anacor Pharmaceuticals Inc (ANAC): VHCP Management’s Top 3 Biotech Picks

Andres Hove and Bong Koh’s VHCP Management revealed its top 3 biotech picks heading into 2015, in a 13F Form filed with the U.S. Securities and Exchange Commission last month.

Keep Reading →

March 2nd, 2015 - Hedge Funds News